Patent assignee · CA · COMPANY

PHOENIX MOLECULAR DESIGNS

4Patents
4Active
4Granted
45Portfolio score

Filing activity: Feb 17, 2017 → Feb 10, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US9771366B2 Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors Chemistry; Metallurgy 6 Active
US10081632B2 Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors Chemistry; Metallurgy 2 Active
US10758530B2 Carboxamide derivatives useful as rsk inhibitors Chemistry; Metallurgy 1 Active
US12378245B2 Crystalline forms of an RSK inhibitor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.